OA05.05 Avelumab vs Docetaxel for Previously Treated Advanced NSCLC: Primary Analysis of the Phase 3 JAVELIN Lung 200 Trial
Conference paper > Summary Text
Authors: F. Barlesi, J. Vansteenkiste, D. Spigel, H. Ishii, M. Garassino, F. De Marinis, M. Özgüroğlu, A. Szczesna, A. Polychronis, R. Uslu, M. Krzakowski, J. Lee, L. Calabro, O. Frontera, B. Ellers-Lenz, M. Bajars, M. Ruisi, K. Park
Journal of Thoracic Oncology, , , International, Summary Text, WoS, vol 13, pp S331-S332